Amgen EVP, CFO Thomas J.W. Dittrich files initial beneficial ownership statement

Amgen EVP and CFO Thomas J.W. Dittrich filed an initial SEC Form 3 beneficial ownership statement, reporting holdings of 16,860 common shares. The disclosure was published via EDGAR on September 4, 2026.

Amgen EVP and CFO Thomas J.W. Dittrich reported 16,860 common shares in an initial SEC Form 3 filing. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amgen Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000318154-26-000139), on September 04, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here